Skip to content
PubMed This is a summary of 10 peer-reviewed journal articles Updated
Hematology

How Often Are Factor XIII Infusions in Pregnancy?

At a Glance

If you have Factor XIII deficiency, you will likely need prophylaxis infusions every two weeks or more frequently during pregnancy. Your expanded blood volume consumes the factor faster, requiring strict monitoring to keep your trough levels above 30% and protect the pregnancy.

If you have Factor XIII (FXIII) deficiency, your prophylaxis infusion (preventative treatment) schedule will change significantly if you become pregnant. While you may be accustomed to receiving infusions once a month, during pregnancy, you will likely need infusions every two weeks, or even more frequently, as your pregnancy progresses [1][2].

Why Does the Schedule Change?

During pregnancy, your body undergoes major physiological changes, including a significant expansion of your blood volume, particularly in the second and third trimesters [1][3]. Because you have more blood circulating in your body, the FXIII factor you infuse is diluted and consumed much faster than when you are not pregnant [1][2]. Therefore, more frequent doses—and sometimes higher dosage amounts—are needed to keep your factor levels steady.

Target Trough Levels

To protect both you and your baby, your medical team will monitor your trough levels—the lowest amount of FXIII in your blood just before your next scheduled dose [1][4].

Factor XIII is essential not only for normal blood clotting but also for proper placental attachment and for maintaining the pregnancy [5][6]. The goal is typically to maintain your trough levels above 30%, though your specific target may evolve depending on your trimester [3][5]. Falling below your target threshold increases the risk of serious complications, such as placental abruption (when the placenta separates from the uterus) and miscarriage (early fetal loss) [5][7].

Always contact your medical team immediately or go to the emergency room if you experience warning signs such as vaginal bleeding, unusual spotting, or severe abdominal cramping.

Personalized Monitoring

Because every woman’s body processes the infused factor differently, there is no single “one-size-fits-all” schedule [2]. Your hematologist and high-risk obstetrician will work together to create a personalized treatment plan [3][8]. This will require frequent blood tests to monitor your trough levels and ensure your infusion schedule is keeping up with your body’s increasing demands [1][4].

Labor, Delivery, and Postpartum Care

Your personalized plan will not stop at pregnancy. Because labor and delivery present significant bleeding risks, your care team will also establish a highly specific dosing strategy for childbirth and the immediate postpartum period to protect you from postpartum hemorrhage [9][10].

While a high-risk pregnancy can feel daunting, with strict adherence to your infusion schedule and close monitoring by your medical team, a successful, healthy pregnancy is very achievable [2][7].

Common questions in this guide

Can You Develop Factor XIII Deficiency Later in Life?Why Does Factor XIII Only Need Monthly Infusions?Are Factor XIII Carriers at Risk During Surgery & Birth?Factor XIII Child Bumped Head? What to Do ImmediatelyWhy Do I Get Cigarette-Paper Scars with FXIII Deficiency?Does Factor XIII Deficiency Cause Permanent Joint Damage?What to Put on a Factor XIII Medical Alert BraceletCan Plasma Treat Factor XIII Deficiency Emergencies?Can I Have Factor XIII With a Normal Clot Test?Tretten vs Corifact for Factor XIII: What's the Difference?
Why does my Factor XIII infusion schedule change during pregnancy?
During pregnancy, your blood volume expands significantly. Because you have more blood circulating, the Factor XIII you infuse is diluted and used up much faster than normal. This means you will need infusions more frequently, often every two weeks or more, to keep your levels steady.
What is a target trough level for Factor XIII?
A trough level is the lowest amount of Factor XIII in your blood right before your next scheduled dose. During pregnancy, doctors typically aim to keep this trough level above 30% to ensure you have enough clotting factor to support the pregnancy and prevent bleeding.
What are the risks if my Factor XIII levels drop too low while pregnant?
If your Factor XIII levels fall below your target threshold, you face a higher risk of severe complications. These include miscarriage or placental abruption, which occurs when the placenta prematurely separates from the uterus.
Will my infusions stop when I go into labor?
No, your treatments will continue and be carefully planned for delivery. Your medical team will establish a specific Factor XIII dosing strategy for childbirth and the immediate postpartum period to protect you from severe bleeding after you deliver.

Questions for Your Doctor

5 questions

  • Based on my current baseline, what specific trough level will we target during each trimester?
  • Will my infusions be coordinated between my hematologist and high-risk obstetrician, and who is my primary contact for schedule changes?
  • Where will my frequent blood draws take place, and how quickly will we have the results to adjust my dose?
  • What is our specific factor replacement plan for my labor, delivery, and postpartum recovery?
  • What specific warning signs or symptoms should prompt me to go to the emergency room immediately between scheduled visits?

Questions for You

3 questions

  • Do I have the flexibility in my work or personal schedule to accommodate bi-weekly or weekly infusions and frequent blood draws?
  • Have I experienced any bleeding complications or early pregnancy losses in the past that I need to discuss in detail with my new care team?
  • Do I have a reliable support system in place to help me manage the increased medical appointments and potential stress of a high-risk pregnancy?

References

References (10)
  1. 1

    Recombinant factor XIII A-subunit in a patient with factor XIII deficiency and recurrent pregnancy loss.

    Al-Khabori M, Pathare A, Menegatti M, Peyvandi F

    Journal of thrombosis and haemostasis : JTH 2018; (16(6)):1052-1054 doi:10.1111/jth.14126.

    PMID: 29665207
  2. 2

    Successful perinatal management of a woman with congenital factor XIII deficiency using recombinant factor XIII: A case report and literature review.

    Ito Y, Tsuji S, Kasahara M, et al.

    The journal of obstetrics and gynaecology research 2024; (50(2)):262-265 doi:10.1111/jog.15819.

    PMID: 37875278
  3. 3

    Congenital factor XIII deficiency: comprehensive overview of the FranceCoag cohort.

    Bouttefroy S, Meunier S, Milien V, et al.

    British journal of haematology 2020; (188(2)):317-320 doi:10.1111/bjh.16133.

    PMID: 31414482
  4. 4

    Factor XIII Deficiency: Laboratory, Molecular, and Clinical Aspects.

    Dorgalaleh A, Jozdani S, Zadeh MK

    Seminars in thrombosis and hemostasis 2025; (51(2)):155-169 doi:10.1055/s-0044-1796673.

    PMID: 39613144
  5. 5

    Gynecological and obstetric outcome in the French cohort of women with factor XIII deficiency.

    Rugeri L, Martinaud C, Beurrier P, et al.

    Thrombosis research 2020; (191()):22-25 doi:10.1016/j.thromres.2020.04.010.

    PMID: 32360976
  6. 6

    Advances of Coagulation Factor XIII.

    Shi DY, Wang SJ

    Chinese medical journal 2017; (130(2)):219-223 doi:10.4103/0366-6999.198007.

    PMID: 28091415
  7. 7

    Factor XIII Deficiency: A Review of Clinical Presentation and Management.

    Pelcovits A, Schiffman F, Niroula R

    Hematology/oncology clinics of North America 2021; (35(6)):1171-1180 doi:10.1016/j.hoc.2021.07.009.

    PMID: 34607717
  8. 8

    Pyopneumothorax Secondary to Pulmonary Tuberculosis Superadded by Congenital Factor XIII Deficiency: A Case Report.

    Bajpai J, Tewari J, Roy S, et al.

    Cureus 2023; (15(10)):e47350 doi:10.7759/cureus.47350.

    PMID: 38022233
  9. 9

    Medical and Surgical Management of Postpartum Hemorrhage in a Woman with Factor XIII Deficiency.

    Cheng M, Nassim J, Angha A, et al.

    Case reports in obstetrics and gynecology 2016; (2016()):7963874 doi:10.1155/2016/7963874.

    PMID: 27635271
  10. 10

    Novel Insights into Heterozygous Factor XIII Deficiency.

    Dorgalaleh A

    Seminars in thrombosis and hemostasis 2024; (50(2)):200-212 doi:10.1055/s-0043-1764471.

    PMID: 36940714

This page is for informational purposes only. Factor XIII treatment schedules during pregnancy must be highly personalized; always consult your hematologist and high-risk obstetrician regarding your specific care plan.

Get notified when new evidence is published on Factor XIII Deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.